NGG-16153-34030
3 vaccinations
3 coded responses
24 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 980 / WA
- Registered
- 2021-03-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-24
Registered in v-safe
-
2021-03-24
Dose 1 — Pfizer-BioNTech
- 2021-03-24
-
2021-03-25
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-26
- 2021-03-27
-
2021-03-28
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-07
-
2021-04-14
Survey response — day 21, dose 1MedDRA: Fatigue, Headache — Feeling: Good · Be unable to do your normal daily activitiesFree text: Two periods of sudden fatigue with headache. Each lasted about 12hrs. No obvious explanation.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-16
Dose 2 — Pfizer-BioNTech
-
2021-04-17
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-07-16
Survey response — 3 months, dose 2MedDRA: Abdominal pain, Pregnancy test false positive — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Abdominal pain - unknown, maybe gallstoneFalse positive pregnancy testMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-16
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-07-22
-
2021-10-16
Dose 3 — Pfizer-BioNTech
-
2021-10-17
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-10-18
- 2021-10-19
- 2021-10-20
- 2021-10-21
- 2021-10-22
- 2021-10-24
- 2021-10-30
- 2021-11-06
- 2021-11-22
-
2022-01-17
Survey response — 3 months, dose 3MedDRA: Fatigue, Headache, Malaise, Pain, Upper respiratory tract irritation — Feeling: Good · Be unable to do your normal daily activitiesFree text: Sick, maybe covid. Didn't check. Head and body ache, mild upper respiratory irritation. No fever. Tired five days.MedDRA releases: 2024-11 · check-in free text available
- 2022-04-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-24 | Pfizer-BioNTech | |
| 2 | 2021-04-16 | Pfizer-BioNTech | |
| 3 | 2021-10-16 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 7 — day 21, dose 1
Symptoms: Two periods of sudden fatigue with headache. Each lasted about 12hrs. No obvious explanation.
Release 9 — 3 months, dose 2
Symptoms: Abdominal pain - unknown, maybe gallstoneFalse positive pregnancy test
Release 10 — 3 months, dose 3
Symptoms: Sick, maybe covid. Didn't check. Head and body ache, mild upper respiratory irritation. No fever. Tired five days.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal pain | ✓ | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pregnancy test false positive | ✓ | · | ✓ |
| SD | Upper respiratory tract irritation | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release